Galecto, Inc. (GLTO) Financials

GLTO Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2023 38.2 million 5.9 million
Sept. 30, 2023 50.0 million 12.7 million
June 30, 2023 58.8 million 15.1 million
March 31, 2023 64.6 million 14.3 million

GLTO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -11.5 million 1.1 million
Sept. 30, 2023 -8.5 million 1.5 million
June 30, 2023 -7.8 million 1.4 million
March 31, 2023 -9.1 million 1.4 million

GLTO Net Income

No data available :(

GLTO Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 33.2 million - 249000
Sept. 30, 2023 44.2 million - 464000
June 30, 2023 52.1 million - 626000
March 31, 2023 53.2 million - 686000

GLTO Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 27.1 million
Sept. 30, 2023 27.1 million
June 30, 2023 26.4 million
March 31, 2023 25.7 million

GLTO Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 - 2.8 million 3.2 million 229000
Sept. 30, 2023 - 2.6 million 3.3 million -
June 30, 2023 - 8.1 million 3.1 million -
March 31, 2023 - 10.4 million 3.1 million -

GLTO Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 1.2 million 229000
Sept. 30, 2023 - 367000
June 30, 2023 - 95000
March 31, 2023 - 139000

GLTO

Price: $19.66

52 week price:
2.01
38.33

Earnings Per Share: -12.11 USD

P/E Ratio: -2.32

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Denmark

Volume: 27417

Market Capitalization: 44.9 million

Links: